Barry Kagan, a director of Dipexium Pharmaceuticals, Inc., has just filed an initial statement of beneficial ownership where 19,810 shares of Dipexium Pharmaceuticals, Inc. were declared. This form is usually filed as a prelude to receiving options or buying company shares, so there may be more to come from Kagan. Kagan operates out of New York, NY. Some additional info was provided as follows:
Options vest as follows: 50% on the date of grant and the remaining 50% vests in equal installments over a 24 month period, subject to accelerated vesting on a change of control.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!